Mraz, Amerine & Associates, Inc. has disclosed its investment holdings in a recent filing, showcasing a total portfolio value of approximately $640 million as of September 30, 2026. This information is significant as it reflects the firm’s strategic positioning in the financial advisory landscape.

According to the filing, Mraz, Amerine & Associates is based in Modesto, California, and operates under the Central Index Key (CIK) number 0001542324. The firm specializes in managing investments for clients, and its recent filing is categorized as a 13F Holdings Report, which is a required submission for institutional investment managers.

The filing indicates that Mraz, Amerine & Associates holds a diverse array of investments, with a total of 198 reported positions. Notable investments include significant stakes in well-known companies such as 3M Co., Abbott Laboratories, and Apple Inc. The firm has demonstrated a clear strategy of investing across various sectors, which may appeal to a broad client base.

In the filing, the Chief Compliance Officer, Deidre Mraz, confirmed the accuracy of the report, stating, "This filing reflects our commitment to transparency and our clients’ interests." The total value reported in the filing is $640,234,362, showcasing the firm’s robust investment capabilities.

This disclosure may impact various stakeholders, including clients, competitors, and market analysts. For clients, it provides insight into the firm’s investment strategies and priorities. Competitors may analyze this information to gauge Mraz, Amerine & Associates’ market positioning and investment trends.

Looking ahead, it remains to be seen how Mraz, Amerine & Associates will adapt its investment strategies in response to market changes and client needs. The filing does not specify any immediate next steps, but it is likely that the firm will continue to monitor its investments closely.